mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.07 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.07 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.07 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.07 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |